cache/b541ea6042275252fd0240e2448ff3ebf469a869791b1abb4448004a40780f6a

CH:CAMPUSBIOTECH

Campus Biotech

  • Privately Held

Company Overview

Metric
Company NameCampus BiotechAlentis TherapeuticsCentre hospitalier universitaire vaudois - CHUVETH Zürich
Symbol
MSH IDCH:CAMPUSBIOTECHCH:ALENTISCH:CHUVCH:ETHZ
MarketPRIVATEPRIVATEPRIVATEPRIVATE
SectorHealthcare & Health ServicesCommercial & Professional ServicesHealthcare & Health ServicesCommercial & Professional Services
IndustryLife SciencesBiotechnologyHealthcareEducation
CountryCHCHCHCH
Stage
Employee Count59
Websitecampusbiotech.chalentis.chchuv.chethz.ch
LinkedIncampus-biotechalentis-therapeutics
Founders

Market Metrics

Metric
Market Cap731.80M
Enterprise Value
Monthly Web Traffic6.83K
Web Traffic Growth-0.59
Valuation
Raised Capital

Financial Performance

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Growth Metrics

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score62.96
28-Day Growth Score62.29
90-Day Growth Score65
365-Day Growth Score87.50

Profitability Ratios

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

Valuation Multiples

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Operational Metrics

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Cash Flow Metrics

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Balance Sheet Metrics

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Efficiency Metrics

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue